This is the authors' abstract. We don't add key points for this paper.
Captopril, a thiol-containing angiotensin-converting enzyme (ACE) inhibitor, is known for its limited stability in biological matrices due to oxidative degradation. This study introduces a validated liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for the quantification of captopril in human plasma, with stabilization achieved through the addition of sodium metabisulphite. Chromatographic separation was carried out using a Zorbax CN (Cyano) column measuring 75 × 4.6 mm with a particle size of 3.5 µm. The mobile phase consisted of methanol and 0.1% formic acid in a 70:30 (v/v) ratio. Detection utilized negative electrospray ionization mode, monitoring multiple reaction monitoring (MRM) transitions of 216.1 → 114.2 for captopril and 219.3 → 117.3 for the internal standard, Captopril D3. Sample preparation involved solid-phase extraction using MCX cartridges. The method was validated in accordance with ICH M10 guidelines. It demonstrated excellent linearity across the concentration range of 5.00 to 799.56 ng/mL, with high sensitivity, accuracy ranging from 99.14 to 101.69%, and precision with a coefficient of variation not exceeding 4.99%. The incorporation of sodium metabisulphite significantly enhanced the stability of captopril in plasma samples. This validated method is suitable for use in pharmacokinetic studies, bioequivalence assessments, and therapeutic drug monitoring.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tawari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: